Conference Coverage (ASCO)

Immuno/Gene Therapy of Colorectal Cancer Reaches the Clinical Trial Stage

Published in Gene Therapy Weekly, July 13th, 1998

Early results from a clinical trial of a T cell gene therapy for colorectal cancer are promising.

K.M. Hege, representing colleagues from Cell Genesys, the University of California, and Stanford University, California, explained the process leading to the induction of clinical trials of a gene therapy designed around autologous T cells for colorectal cancer, at the 34th Annual Meeting of the American Society of Clinical Oncology, held May 16-19, 1998, in Los Angeles, California (abstract "T Cell Gene Therapy of Colorectal Cancer with Autologous CC49-Zeta Gene-Modified CD4 and CD8 T Cells").

"The antigen specificity of human T cells can be redirected...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1998-07-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry